Icrucumab, CAS 1024603-92-6

Product Description: Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]LoRusso PM, et al. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Invest New Drugs. 2014 Apr;32(2):303-11.

CAS Number: 1024603-92-6

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: VEGFR

• Artikelnummer: MEXHY-P99364-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99364-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK